Knight Therapeutics Inc. GUD.TO
TSX
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 104.13M | 85.33M | 102.58M | 83.31M | 84.82M |
| Total Receivables | 104.30M | 102.00M | 112.20M | 100.82M | 93.43M |
| Inventory | 96.56M | 101.80M | 101.67M | 99.09M | 103.67M |
| Prepaid Expenses | 5.74M | 5.50M | 3.75M | 4.74M | 5.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 310.73M | 294.63M | 320.20M | 287.97M | 287.67M |
|
|
|||||
| Total Current Assets | 310.73M | 294.63M | 320.20M | 287.97M | 287.67M |
| Net Property, Plant & Equipment | 22.58M | 22.09M | 21.76M | 15.99M | 15.64M |
| Long-term Investments | 69.14M | 69.38M | 68.28M | 65.63M | 66.22M |
| Goodwill | 69.14M | 69.38M | 68.28M | 65.63M | 66.22M |
| Total Other Intangibles | 242.92M | 242.84M | 253.63M | 276.79M | 270.96M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 58.59M | 57.63M | 58.10M | 58.76M | 60.69M |
| Total Assets | 750.30M | 735.75M | 778.44M | 763.10M | 752.81M |
|
|
|||||
| Total Accounts Payable | 96.23M | 95.51M | 105.55M | 88.15M | 81.02M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 135.70K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.35M | 13.89M | 15.48M | 14.54M | 15.46M |
| Total Finance Division Other Current Liabilities | 18.90M | 19.81M | 16.84M | 17.70M | 13.13M |
| Total Other Current Liabilities | 18.90M | 19.81M | 16.84M | 17.70M | 13.13M |
| Total Current Liabilities | 129.48M | 129.21M | 137.87M | 120.53M | 109.61M |
|
|
|||||
| Total Current Liabilities | 129.48M | 129.21M | 137.87M | 120.53M | 109.61M |
| Long-Term Debt | 3.92M | 4.81M | 29.18M | 37.32M | 56.53M |
| Short-term Debt | -- | -- | -- | 135.70K | -- |
| Capital Leases | 5.35M | 5.44M | 5.33M | 4.83M | 4.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 51.42M | 33.94M | 42.06M | 40.83M | 31.88M |
| Total Liabilities | 190.16M | 173.40M | 214.44M | 203.50M | 202.30M |
|
|
|||||
| Common Stock & APIC | 395.07M | 393.29M | 398.45M | 410.31M | 403.70M |
| Retained Earnings | 108.85M | 110.70M | 115.23M | 108.63M | 100.81M |
| Treasury Stock & Other | 56.22M | 58.36M | 50.33M | 40.65M | 45.99M |
| Total Common Equity | 560.14M | 562.35M | 564.01M | 559.60M | 550.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 560.14M | 562.35M | 564.01M | 559.60M | 550.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 560.14M | 562.35M | 564.01M | 559.60M | 550.50M |
|
|
|||||